Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cells in Breast Cancer
NCT03450044Phase 2Completed
- Sponsor
- Fundación Salud de los Andes
- Start
- Jan 2014
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer (2 arms), sponsored by Fundación Salud de los Andes. Primary endpoint: Adverse effects at 1 year. Started Jan 2014; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03450044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450044.